Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Ophthalmology
• Genetics

Background:

• Alzheimer's disease (AD) is a progressive dementia characterized by amyloid plaques and neurofibrillary tangles.
• Similar pathological hallmarks are observed in retinal neurodegenerative diseases like age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy (DR).
• Epidemiological studies suggest associations between AD and these retinal diseases, indicating shared risk factors and pathological events.

Purpose of the Study:

• To review the role of Apolipoprotein E (APOE) in retinal neurodegenerative diseases.
• To discuss the overlapping molecular pathways between Alzheimer's disease and retinal diseases.
• To explore the influence of APOE alleles on AD and various retinal conditions.

Main Methods:

• Literature review of epidemiological studies and molecular research.
• Analysis of the role of Apolipoprotein E (APOE) in Alzheimer's disease and retinal diseases.
• Discussion of common pathological events and risk factors, including APOE genotype.

Main Results:

• The APOE ε4 allele is a known risk factor for late-onset AD but shows a protective effect in AMD.
• Conversely, the APOE ε2 allele, protective in AD, is implicated as a risk factor in AMD and glaucoma.
• APOE influences amyloid-beta and tau pathology, inflammation, vascular integrity, glucose metabolism, and VEGF signaling.

Conclusions:

• Significant overlap exists in the molecular pathways of Alzheimer's disease and retinal neurodegenerative diseases.
• APOE plays a complex and differential role in the pathogenesis of AD and retinal diseases.
• Understanding these shared pathways and APOE's role could lead to novel therapeutic strategies for both conditions.